Galaxy
High-throughput boosting. Compatible with manual workflows and liquid handlers.
Receive your quote directly from the manufacturer.
Cargo Flexibility
Screen small molecules, DELs, peptides and oligos
Easy Workflow Integration
Compatible with both manual workflows and liquid handlers
Cell and Buffer Flexibility
Compatible across cell lines, primary immune and stemcells
Multiplexed delivery of biomolecules for next-gen cell engineering
Advancing cell engineering for drug discovery demands precise, high-efficiency delivery across diverse cell types. Multiplexed intracellular delivery remains a key challenge, especially in high-throughput workflows.
Discover how the Portal Galaxy system integrates with automated liquid handling to streamline mechanoporation, and how it enables reliable co-delivery of CRISPR RNP, mRNA, and more, enhancing screening and intracellular protein detection.
A portal to another world – Automated cell engineering in drug discovery
Tuesday, October 21, 2025
To better suit your schedule and time zone, this webinar will be offered in two separate sessions:
Session 1 broadcasting at 09:00 BST | 10:00 CEST
Session 2 broadcasting at 13:00 EDT | 10:00 PDT
Efficient delivery of biomolecules such as small molecules, proteins, peptides, and intracellular assays remains a critical challenge to both cell engineering and drug discovery across scales. While electroporation is widely used, it has high costs, low cell survival rates, and labor-intensive workflows. Mechanoporation offers a promising alternative, though traditional implementations have struggled to achieve scalability.
Join Dr. Armon Sharei, Portal Bio, and Dennis Condy, Eppendorf, as they discuss how the integration of advanced mechanoporation technology with automated liquid handling enables a cost-effective, high-throughput solution for next-generation cell engineering and drug screening workflows, while also maintaining reproducibility across experiments for greater confidence in results.
Key learning objectives:
- Uncover how mechanoporation opens a whole new galaxy of cargo delivery
- Explore how to leverage automation to go beyond current drug screening and cell engineering workflows
- Discover how to maintain reproducibility whilst boosting your sample throughput
Who should attend?
- Discovery and R&D groups across drug discovery and cell therapy
Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.
